0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha L-Iduronidase Market Research Report 2025
Published Date: 2025-07-09
|
Report Code: QYRE-Auto-23S10074
Home | Market Reports | Health| Pharmacy
Global Alpha L Iduronidase Market Insights Forecast to 2028
BUY CHAPTERS

Global Alpha L-Iduronidase Market Research Report 2025

Code: QYRE-Auto-23S10074
Report
2025-07-09
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Alpha L-Iduronidase Market

The global market for Alpha L-Iduronidase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).
North American market for Alpha L-Iduronidase is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Alpha L-Iduronidase is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Alpha L-Iduronidase include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc, Ossianix Inc, Rain Bio Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha L-Iduronidase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha L-Iduronidase.
The Alpha L-Iduronidase market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha L-Iduronidase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha L-Iduronidase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alpha L-Iduronidase Market Report

Report Metric Details
Report Name Alpha L-Iduronidase Market
Segment by Type
  • IDUA
  • EC 3.2.1.76
Segment by Application
  • Oncology
  • Dermatology
  • Immunology
  • Musculoskeletal Disorders
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc, Ossianix Inc, Rain Bio Inc, RegenxBio Inc, Tega Therapeutics Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alpha L-Iduronidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alpha L-Iduronidase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Alpha L-Iduronidase Market report?

Ans: The main players in the Alpha L-Iduronidase Market are ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc, Ossianix Inc, Rain Bio Inc, RegenxBio Inc, Tega Therapeutics Inc

What are the Application segmentation covered in the Alpha L-Iduronidase Market report?

Ans: The Applications covered in the Alpha L-Iduronidase Market report are Oncology, Dermatology, Immunology, Musculoskeletal Disorders

What are the Type segmentation covered in the Alpha L-Iduronidase Market report?

Ans: The Types covered in the Alpha L-Iduronidase Market report are IDUA, EC 3.2.1.76

1 Alpha L-Iduronidase Market Overview
1.1 Product Definition
1.2 Alpha L-Iduronidase by Type
1.2.1 Global Alpha L-Iduronidase Market Value Comparison by Type (2024 VS 2031)
1.2.2 IDUA
1.2.3 EC 3.2.1.76
1.3 Alpha L-Iduronidase by Application
1.3.1 Global Alpha L-Iduronidase Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Dermatology
1.3.4 Immunology
1.3.5 Musculoskeletal Disorders
1.4 Global Alpha L-Iduronidase Market Size Estimates and Forecasts
1.4.1 Global Alpha L-Iduronidase Revenue 2020-2031
1.4.2 Global Alpha L-Iduronidase Sales 2020-2031
1.4.3 Global Alpha L-Iduronidase Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alpha L-Iduronidase Market Competition by Manufacturers
2.1 Global Alpha L-Iduronidase Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alpha L-Iduronidase Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alpha L-Iduronidase Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alpha L-Iduronidase, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alpha L-Iduronidase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha L-Iduronidase, Product Type & Application
2.7 Global Key Manufacturers of Alpha L-Iduronidase, Date of Enter into This Industry
2.8 Global Alpha L-Iduronidase Market Competitive Situation and Trends
2.8.1 Global Alpha L-Iduronidase Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alpha L-Iduronidase Players Market Share by Revenue
2.8.3 Global Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alpha L-Iduronidase Market Scenario by Region
3.1 Global Alpha L-Iduronidase Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alpha L-Iduronidase Sales by Region: 2020-2031
3.2.1 Global Alpha L-Iduronidase Sales by Region: 2020-2025
3.2.2 Global Alpha L-Iduronidase Sales by Region: 2026-2031
3.3 Global Alpha L-Iduronidase Revenue by Region: 2020-2031
3.3.1 Global Alpha L-Iduronidase Revenue by Region: 2020-2025
3.3.2 Global Alpha L-Iduronidase Revenue by Region: 2026-2031
3.4 North America Alpha L-Iduronidase Market Facts & Figures by Country
3.4.1 North America Alpha L-Iduronidase Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alpha L-Iduronidase Sales by Country (2020-2031)
3.4.3 North America Alpha L-Iduronidase Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alpha L-Iduronidase Market Facts & Figures by Country
3.5.1 Europe Alpha L-Iduronidase Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alpha L-Iduronidase Sales by Country (2020-2031)
3.5.3 Europe Alpha L-Iduronidase Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha L-Iduronidase Market Facts & Figures by Region
3.6.1 Asia Pacific Alpha L-Iduronidase Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alpha L-Iduronidase Sales by Region (2020-2031)
3.6.3 Asia Pacific Alpha L-Iduronidase Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alpha L-Iduronidase Market Facts & Figures by Country
3.7.1 Latin America Alpha L-Iduronidase Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alpha L-Iduronidase Sales by Country (2020-2031)
3.7.3 Latin America Alpha L-Iduronidase Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha L-Iduronidase Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha L-Iduronidase Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alpha L-Iduronidase Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alpha L-Iduronidase Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alpha L-Iduronidase Sales by Type (2020-2031)
4.1.1 Global Alpha L-Iduronidase Sales by Type (2020-2025)
4.1.2 Global Alpha L-Iduronidase Sales by Type (2026-2031)
4.1.3 Global Alpha L-Iduronidase Sales Market Share by Type (2020-2031)
4.2 Global Alpha L-Iduronidase Revenue by Type (2020-2031)
4.2.1 Global Alpha L-Iduronidase Revenue by Type (2020-2025)
4.2.2 Global Alpha L-Iduronidase Revenue by Type (2026-2031)
4.2.3 Global Alpha L-Iduronidase Revenue Market Share by Type (2020-2031)
4.3 Global Alpha L-Iduronidase Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alpha L-Iduronidase Sales by Application (2020-2031)
5.1.1 Global Alpha L-Iduronidase Sales by Application (2020-2025)
5.1.2 Global Alpha L-Iduronidase Sales by Application (2026-2031)
5.1.3 Global Alpha L-Iduronidase Sales Market Share by Application (2020-2031)
5.2 Global Alpha L-Iduronidase Revenue by Application (2020-2031)
5.2.1 Global Alpha L-Iduronidase Revenue by Application (2020-2025)
5.2.2 Global Alpha L-Iduronidase Revenue by Application (2026-2031)
5.2.3 Global Alpha L-Iduronidase Revenue Market Share by Application (2020-2031)
5.3 Global Alpha L-Iduronidase Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ArmaGen Inc
6.1.1 ArmaGen Inc Company Information
6.1.2 ArmaGen Inc Description and Business Overview
6.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ArmaGen Inc Alpha L-Iduronidase Product Portfolio
6.1.5 ArmaGen Inc Recent Developments/Updates
6.2 BioStrategies LC
6.2.1 BioStrategies LC Company Information
6.2.2 BioStrategies LC Description and Business Overview
6.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioStrategies LC Alpha L-Iduronidase Product Portfolio
6.2.5 BioStrategies LC Recent Developments/Updates
6.3 Denali Therapeutics Inc
6.3.1 Denali Therapeutics Inc Company Information
6.3.2 Denali Therapeutics Inc Description and Business Overview
6.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolio
6.3.5 Denali Therapeutics Inc Recent Developments/Updates
6.4 EdiGene Inc
6.4.1 EdiGene Inc Company Information
6.4.2 EdiGene Inc Description and Business Overview
6.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EdiGene Inc Alpha L-Iduronidase Product Portfolio
6.4.5 EdiGene Inc Recent Developments/Updates
6.5 Gain Therapeutics Inc
6.5.1 Gain Therapeutics Inc Company Information
6.5.2 Gain Therapeutics Inc Description and Business Overview
6.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolio
6.5.5 Gain Therapeutics Inc Recent Developments/Updates
6.6 Immusoft Corp
6.6.1 Immusoft Corp Company Information
6.6.2 Immusoft Corp Description and Business Overview
6.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Immusoft Corp Alpha L-Iduronidase Product Portfolio
6.6.5 Immusoft Corp Recent Developments/Updates
6.7 JCR Pharmaceuticals Co Ltd
6.7.1 JCR Pharmaceuticals Co Ltd Company Information
6.7.2 JCR Pharmaceuticals Co Ltd Description and Business Overview
6.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolio
6.7.5 JCR Pharmaceuticals Co Ltd Recent Developments/Updates
6.8 Orchard Therapeutics Plc
6.8.1 Orchard Therapeutics Plc Company Information
6.8.2 Orchard Therapeutics Plc Description and Business Overview
6.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolio
6.8.5 Orchard Therapeutics Plc Recent Developments/Updates
6.9 Ossianix Inc
6.9.1 Ossianix Inc Company Information
6.9.2 Ossianix Inc Description and Business Overview
6.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ossianix Inc Alpha L-Iduronidase Product Portfolio
6.9.5 Ossianix Inc Recent Developments/Updates
6.10 Rain Bio Inc
6.10.1 Rain Bio Inc Company Information
6.10.2 Rain Bio Inc Description and Business Overview
6.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Rain Bio Inc Alpha L-Iduronidase Product Portfolio
6.10.5 Rain Bio Inc Recent Developments/Updates
6.11 RegenxBio Inc
6.11.1 RegenxBio Inc Company Information
6.11.2 RegenxBio Inc Description and Business Overview
6.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.11.4 RegenxBio Inc Alpha L-Iduronidase Product Portfolio
6.11.5 RegenxBio Inc Recent Developments/Updates
6.12 Tega Therapeutics Inc
6.12.1 Tega Therapeutics Inc Company Information
6.12.2 Tega Therapeutics Inc Description and Business Overview
6.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolio
6.12.5 Tega Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha L-Iduronidase Industry Chain Analysis
7.2 Alpha L-Iduronidase Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha L-Iduronidase Production Mode & Process Analysis
7.4 Alpha L-Iduronidase Sales and Marketing
7.4.1 Alpha L-Iduronidase Sales Channels
7.4.2 Alpha L-Iduronidase Distributors
7.5 Alpha L-Iduronidase Customer Analysis
8 Alpha L-Iduronidase Market Dynamics
8.1 Alpha L-Iduronidase Industry Trends
8.2 Alpha L-Iduronidase Market Drivers
8.3 Alpha L-Iduronidase Market Challenges
8.4 Alpha L-Iduronidase Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Alpha L-Iduronidase Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alpha L-Iduronidase Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alpha L-Iduronidase Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alpha L-Iduronidase Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Alpha L-Iduronidase Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alpha L-Iduronidase Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alpha L-Iduronidase Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alpha L-Iduronidase Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alpha L-Iduronidase, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alpha L-Iduronidase, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alpha L-Iduronidase, Product Type & Application
 Table 12. Global Key Manufacturers of Alpha L-Iduronidase, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alpha L-Iduronidase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha L-Iduronidase as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alpha L-Iduronidase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alpha L-Iduronidase Sales by Region (2020-2025) & (K Units)
 Table 18. Global Alpha L-Iduronidase Sales Market Share by Region (2020-2025)
 Table 19. Global Alpha L-Iduronidase Sales by Region (2026-2031) & (K Units)
 Table 20. Global Alpha L-Iduronidase Sales Market Share by Region (2026-2031)
 Table 21. Global Alpha L-Iduronidase Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alpha L-Iduronidase Revenue Market Share by Region (2020-2025)
 Table 23. Global Alpha L-Iduronidase Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alpha L-Iduronidase Revenue Market Share by Region (2026-2031)
 Table 25. North America Alpha L-Iduronidase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alpha L-Iduronidase Sales by Country (2020-2025) & (K Units)
 Table 27. North America Alpha L-Iduronidase Sales by Country (2026-2031) & (K Units)
 Table 28. North America Alpha L-Iduronidase Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alpha L-Iduronidase Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alpha L-Iduronidase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alpha L-Iduronidase Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Alpha L-Iduronidase Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Alpha L-Iduronidase Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alpha L-Iduronidase Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alpha L-Iduronidase Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alpha L-Iduronidase Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Alpha L-Iduronidase Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Alpha L-Iduronidase Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alpha L-Iduronidase Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alpha L-Iduronidase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alpha L-Iduronidase Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Alpha L-Iduronidase Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Alpha L-Iduronidase Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alpha L-Iduronidase Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alpha L-Iduronidase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alpha L-Iduronidase Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Alpha L-Iduronidase Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Alpha L-Iduronidase Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alpha L-Iduronidase Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alpha L-Iduronidase Sales (K Units) by Type (2020-2025)
 Table 51. Global Alpha L-Iduronidase Sales (K Units) by Type (2026-2031)
 Table 52. Global Alpha L-Iduronidase Sales Market Share by Type (2020-2025)
 Table 53. Global Alpha L-Iduronidase Sales Market Share by Type (2026-2031)
 Table 54. Global Alpha L-Iduronidase Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alpha L-Iduronidase Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alpha L-Iduronidase Revenue Market Share by Type (2020-2025)
 Table 57. Global Alpha L-Iduronidase Revenue Market Share by Type (2026-2031)
 Table 58. Global Alpha L-Iduronidase Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Alpha L-Iduronidase Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Alpha L-Iduronidase Sales (K Units) by Application (2020-2025)
 Table 61. Global Alpha L-Iduronidase Sales (K Units) by Application (2026-2031)
 Table 62. Global Alpha L-Iduronidase Sales Market Share by Application (2020-2025)
 Table 63. Global Alpha L-Iduronidase Sales Market Share by Application (2026-2031)
 Table 64. Global Alpha L-Iduronidase Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alpha L-Iduronidase Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alpha L-Iduronidase Revenue Market Share by Application (2020-2025)
 Table 67. Global Alpha L-Iduronidase Revenue Market Share by Application (2026-2031)
 Table 68. Global Alpha L-Iduronidase Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Alpha L-Iduronidase Price (US$/Unit) by Application (2026-2031)
 Table 70. ArmaGen Inc Company Information
 Table 71. ArmaGen Inc Description and Business Overview
 Table 72. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. ArmaGen Inc Alpha L-Iduronidase Product
 Table 74. ArmaGen Inc Recent Developments/Updates
 Table 75. BioStrategies LC Company Information
 Table 76. BioStrategies LC Description and Business Overview
 Table 77. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BioStrategies LC Alpha L-Iduronidase Product
 Table 79. BioStrategies LC Recent Developments/Updates
 Table 80. Denali Therapeutics Inc Company Information
 Table 81. Denali Therapeutics Inc Description and Business Overview
 Table 82. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Denali Therapeutics Inc Alpha L-Iduronidase Product
 Table 84. Denali Therapeutics Inc Recent Developments/Updates
 Table 85. EdiGene Inc Company Information
 Table 86. EdiGene Inc Description and Business Overview
 Table 87. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. EdiGene Inc Alpha L-Iduronidase Product
 Table 89. EdiGene Inc Recent Developments/Updates
 Table 90. Gain Therapeutics Inc Company Information
 Table 91. Gain Therapeutics Inc Description and Business Overview
 Table 92. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Gain Therapeutics Inc Alpha L-Iduronidase Product
 Table 94. Gain Therapeutics Inc Recent Developments/Updates
 Table 95. Immusoft Corp Company Information
 Table 96. Immusoft Corp Description and Business Overview
 Table 97. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Immusoft Corp Alpha L-Iduronidase Product
 Table 99. Immusoft Corp Recent Developments/Updates
 Table 100. JCR Pharmaceuticals Co Ltd Company Information
 Table 101. JCR Pharmaceuticals Co Ltd Description and Business Overview
 Table 102. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product
 Table 104. JCR Pharmaceuticals Co Ltd Recent Developments/Updates
 Table 105. Orchard Therapeutics Plc Company Information
 Table 106. Orchard Therapeutics Plc Description and Business Overview
 Table 107. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Orchard Therapeutics Plc Alpha L-Iduronidase Product
 Table 109. Orchard Therapeutics Plc Recent Developments/Updates
 Table 110. Ossianix Inc Company Information
 Table 111. Ossianix Inc Description and Business Overview
 Table 112. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ossianix Inc Alpha L-Iduronidase Product
 Table 114. Ossianix Inc Recent Developments/Updates
 Table 115. Rain Bio Inc Company Information
 Table 116. Rain Bio Inc Description and Business Overview
 Table 117. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Rain Bio Inc Alpha L-Iduronidase Product
 Table 119. Rain Bio Inc Recent Developments/Updates
 Table 120. RegenxBio Inc Company Information
 Table 121. RegenxBio Inc Description and Business Overview
 Table 122. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. RegenxBio Inc Alpha L-Iduronidase Product
 Table 124. RegenxBio Inc Recent Developments/Updates
 Table 125. Tega Therapeutics Inc Company Information
 Table 126. Tega Therapeutics Inc Description and Business Overview
 Table 127. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Tega Therapeutics Inc Alpha L-Iduronidase Product
 Table 129. Tega Therapeutics Inc Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Alpha L-Iduronidase Distributors List
 Table 133. Alpha L-Iduronidase Customers List
 Table 134. Alpha L-Iduronidase Market Trends
 Table 135. Alpha L-Iduronidase Market Drivers
 Table 136. Alpha L-Iduronidase Market Challenges
 Table 137. Alpha L-Iduronidase Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alpha L-Iduronidase
 Figure 2. Global Alpha L-Iduronidase Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alpha L-Iduronidase Market Share by Type: 2024 & 2031
 Figure 4. IDUA Product Picture
 Figure 5. EC 3.2.1.76 Product Picture
 Figure 6. Global Alpha L-Iduronidase Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Alpha L-Iduronidase Market Share by Application: 2024 & 2031
 Figure 8. Oncology
 Figure 9. Dermatology
 Figure 10. Immunology
 Figure 11. Musculoskeletal Disorders
 Figure 12. Global Alpha L-Iduronidase Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Alpha L-Iduronidase Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Alpha L-Iduronidase Sales (2020-2031) & (K Units)
 Figure 15. Global Alpha L-Iduronidase Average Price (US$/Unit) & (2020-2031)
 Figure 16. Alpha L-Iduronidase Report Years Considered
 Figure 17. Alpha L-Iduronidase Sales Share by Manufacturers in 2024
 Figure 18. Global Alpha L-Iduronidase Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Alpha L-Iduronidase Players: Market Share by Revenue in Alpha L-Iduronidase in 2024
 Figure 20. Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Alpha L-Iduronidase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Alpha L-Iduronidase Sales Market Share by Country (2020-2031)
 Figure 23. North America Alpha L-Iduronidase Revenue Market Share by Country (2020-2031)
 Figure 24. United States Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Alpha L-Iduronidase Sales Market Share by Country (2020-2031)
 Figure 27. Europe Alpha L-Iduronidase Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Alpha L-Iduronidase Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Alpha L-Iduronidase Revenue Market Share by Region (2020-2031)
 Figure 35. China Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Alpha L-Iduronidase Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Alpha L-Iduronidase Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Alpha L-Iduronidase Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Alpha L-Iduronidase Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Alpha L-Iduronidase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Alpha L-Iduronidase by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Alpha L-Iduronidase by Type (2020-2031)
 Figure 56. Global Alpha L-Iduronidase Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Alpha L-Iduronidase by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Alpha L-Iduronidase by Application (2020-2031)
 Figure 59. Global Alpha L-Iduronidase Price (US$/Unit) by Application (2020-2031)
 Figure 60. Alpha L-Iduronidase Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS